Objectives: Cell migration is necessary for numerous physiological cell processes.
| INTRODUCTION
The resident pools of mesenchymal stem cells (MSCs) in many tissues are responsible for wound healing and immunomodulation. Therefore, the goal of stem cell-based therapies is to exploit these cells for the management of diseases associated with tissue dysfunction and immunologic deficiency, either through the pharmacological mobilization of host stem cells in vivo or the transplantation of ex vivo-manipulated MSCs from an exogenous source. [1] [2] [3] In the latter case, ex vivo culture conditions play important roles in determining the fate of the transplanted cells. Notably, most, if not all, currently well-established in vitro culture systems cannot effectively recapitulate the complex architecture and properties of the native in vivo cell milieu. 4, 5 Hence, cellular characteristics, including proliferation, differentiation and migration abilities, tend to be altered, particularly during long-term cell expansion under large-scale cell manufacturing conditions. 6, 7 In this context, maintaining the migration and homing capacities of the cells during ex vivo culture and subsequently ensuring the ability of transplanted MSCs to traffic to and reach the site of injury are prerequisites for utilizing their regeneration potential. that culture-expanded MSCs almost completely lose their engraftment potential in in vitro cell culture systems. 9, 10 In recent years, preconditioning of MSCs before infusion using various stimuli, such as inflammation 11, 12 and hypoxia, 13, 14 has been employed for cell pretreatment before transplantation. Although mounting evidence has demonstrated that a single inflammatory stimulus or hypoxia alone is able to improve cell migration, an optimized pretreatment for cell manipulation could potentially consist of a combination of several inflammatory and/or hypoxic pretreatments. With this hypothesis in mind, various combinations of chemokines/cytokines 11, 15, 16 or stimulus strategies 17, 18 have been tested. Unfortunately, these efforts
have not led to a predictable, or ideally a synergistic, outcome. An analysis of the data published thus far suggests that the dose and time used for cell preconditioning under inflammatory and/or hypoxic conditions must be optimized for translation into clinical use. 11, 17 Previous data have shown that pretreating cells with inflammatory mediators, such as tumour necrosis factor-α (TNF-α), results in a concentrationdependent effect on cell migration. 19 Furthermore, the migration capacity of MSCs is improved at a very low oxygen concentration (1%).
20
However, very high concentrations of chemicals or very low concentrations of oxygen can lead to harmful changes in cell properties.
12,21
It has been hypothesized that the combination of a hypoxic stimulus and an inflammatory stimulus could be used to avoid the need for high chemical concentrations and very low oxygen concentrations to reach a satisfactory level of cell migration.
In our previous studies examining cell pretreatment, cell medium containing TNF-α (10 ng/mL) and interleukin-1β (IL-1β) (5 ng/mL) was used to establish the inflammatory stimulus, while the hypoxic condition was established using a humidified atmosphere containing 2% O 2 . 17 However, at this particular inflammatory dose, the dual stimuli did not have any additional effects on cell migration. Given that 2% O 2 has been demonstrated to be safe for a standard duration (eg, for 24 hour) in numerous studies, 22, 23 in the present study, we chose to decrease the concentration of inflammatory cytokines by 10-fold (based on our prescreening) and sought to identify safe but effective conditions involving both a hypoxic stimulus and a low-dose inflammatory stimulus for cell conditioning.
| METHODS

| BMMSCs and group design
Human bone marrow (BM) samples to be used for cell isolation were obtained from three systemically healthy donors. All donors signed informed consents for contributing their BM samples for research purposes, and the experimental procedure was approved by the Institutional Review Board of the School of Stomatology, Fourth
Military Medical University (FMMU), Xi'an, China. Human bone marrow-derived mesenchymal stem cells (BMMSCs) were isolated and characterized using the methods described in our previous work.
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Briefly, primary cells were harvested from the BM samples and then purified using a limiting dilution technique. The obtained cells at passage 3 (P3) were subjected to colony-forming and multiplication assays, flow cytometry analysis and evaluations of osteogenic/adipogenic differentiation. Cells at P3-P5 were used in subsequent experiments.
We treated the cell cultures with an inflammatory stimulus, a hypoxic stimulus and both inflammatory and hypoxic stimuli for 24 hours; these cells constituted the inflammation group, the hypoxia group and the dual-stimulus group, respectively. Cultures without an inflammatory or hypoxic stimulus under a parallel 24 hours incubation served as controls (no-stimulus group). Instead of using TNF-α and IL-1β at concentrations of 10 and 5 ng/mL, respectively, 17,18 the inflammatory stimulus medium used in this study was produced by adding TNF-α at 1 ng/mL and IL-1β at 0.5 ng/mL (both from Sigma-Aldrich, St. Louis, MO, USA) to complete medium. The cultures in the hypoxia group and the dual-stimulus group were incubated in a humidified atmosphere containing 2% O 2 , while a standard oxygen concentration (20% O 2 ) was used for the inflammation group and the no-stimulus group.
| Real-time PCR analysis
Relative CXCR4 mRNA expression in the incubated cells (P4) was evaluated through real-time PCR analysis. According to our group design, the cells were incubated for 24 hours, and total RNA was isolated using the TRIzol reagent (Invitrogen Life Technology, Carlsbad, CA, USA). The RNA was subsequently reverse transcribed to cDNA using the RevertAid First Strand cDNA Synthesis Kit (Takara, Bio, Otsu, Japan). The sequences of the primers for CXCR4 and GAPDH were previously described. 17 Relative CXCR4 expression was evaluated using the CFX Connect™ Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA).
| Western blot analysis
Relative CXCR4 protein expression in the incubated cells (P4) was evaluated through Western blot analysis. The cells were incubated as described above (for the CXCR4 gene analysis), and total protein was extracted using lysis buffer (Sigma-Aldrich). The CXCR4 and β-tubulin proteins were analysed as described previously. 
| Immunofluorescence analysis
CXCR4 protein expression in the incubated BMMSCs (P4) was further detected via immunofluorescent staining. The methods employed for this analysis were described in detail previously. 
| Tablet scratch assay
The migratory ability of the incubated cells was first determined using a tablet scratch assay. Briefly, BMMSCs (P4) were cultured in six-well culture dishes (2 × 10 5 cells per well) and pre-incubated for 24 hours according to the group design. Then, mitomycin C (10 μg/mL) was added to each culture system to inhibit proliferation. After another 2 hour of culture, a cell-free strip was generated by scratching the cellular monolayer with a pipette tip (1000 μL), and the resultant baseline was then recorded. Following incubation for another 20 hour in complete medium under a humidified atmosphere containing 20% O 2 , the cells that had migrated with respect to the baseline were photographed, and an inverted microscope (Olympus, Tokyo, Japan) was used for cell counting.
| Transwell assay
The migratory ability of incubated cells along a stromal-derived factor-1α
(SDF-1α) gradient was determined using a Transwell membrane system, 17 which contained an 8 μm pore polycarbonate membrane in 24-well culture plates. Briefly, incubated BMMSCs (P4) were transferred to the upper chamber of a Transwell membrane system (1 × 10 5 cells per well). To assess the migration of the cells, the same amount of incubated cells were pretreated for another 30 minutes with 5 μg/mL AMD3100 (a CXCR4 antagonist) 24 and then transferred to the upper chamber.
Then, 600 μL of complete medium containing 100 ng/mL SDF-1α was added to each lower chamber. 
| Cell proliferation analysis
The effects of different pretreatments on cell proliferation were assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma-Aldrich) assay. The methods for this assay were described in detail previously.
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| Cell differentiation analysis
The effects of different pretreatments on the expression of osteogenic and adipogenic genes/proteins were evaluated using real-time previously. 18 Furthermore, the osteogenic differentiation of the cells in each group was assessed through Alizarin Red staining, while the adipogenic potential was analysed using Oil Red O staining. In parallel, the cells in all groups were incubated with osteogenic medium and adipogenic medium. After 4 weeks of osteogenic induction, the cells were fixed with 4% paraformaldehyde for 30 minutes, followed by Alizarin
Red (Sigma-Aldrich) staining. After 3 weeks of adipogenic induction, the cells were fixed and then stained with Oil Red O for 15 minutes. Finally, the mineral nodules and lipid droplets were imaged, and dissolved solutions of the samples were quantitatively measured at 560 nm.
| Immunosuppression analyses
The effects of different pretreatments on cell immunomodulatory activity were evaluated by detecting the proliferation/apoptosis rate of peripheral blood mononuclear cells (PBMNCs). After co-culture with pretreated cells, PBMNCs were subjected to analysis of the proliferation/apoptosis rate; the methods for this analysis were described in detail previously. 25, 26 Briefly, density-gradient centrifugation was used to extracted PBMNCs from fresh blood derived from three systemically healthy donors. Prior to co-culture, PBMNCs were activated with 10 μg/mL phytohemagglutinin (PHA, Sigma-Aldrich) for 24 hours in Roswell Park Memorial Institute (RPMI)-1640 medium.
Then, mitomycin C (10 μg/mL) was added to the culture medium to inhibit proliferation. Subsequently, the PBMNCs were co-cultured with the pretreated BMMSCs at a 1:24 ratio (BMMSC:PBMNC) for the designated times, as described previously. 
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After 72 hours of co-culture, the apoptosis rate of the PBMNCs was detected using an Annexin V/propidium iodide (Annexin V/PI) kit (7 Sea Pharmtech) and analysed with a flow cytometer.
| Statistical analyses
Each experiment was repeated at least three times for three cell lines.
The numerical data are expressed as the mean ± standard deviation (SD). One-way analysis of variance (ANOVA) followed by Tukey's post hoc test or two-way ANOVA was performed using GraphPad Prism 5
software to analyse the obtained data. P<.05 was considered statistically significant.
| RESULTS
| Isolation and identification of BMMSCs
Primary cells were successfully isolated from the BM samples from three donors ( Figure 1A) . After purification via a limited dilution method, all cells derived from the three individuals exhibited the ability to form cell colonies ( Figure 1B ), proliferate during culture ( Figure 1C) and transdifferentiate into osteogenic and adipogenic lineages in vitro ( Figure 1D ). In addition, the isolated BMMSCs were positive for the CD146 and STRO-1, while they did not express hematopoietic markers, such as CD31 and CD34 ( Figure 1E ).
| An inflammatory stimulus and a hypoxic stimulus synergistically increase CXCR4 expression in BMMSCs
Real-time PCR analysis showed that the combination of an inflammatory stimulus and a hypoxic stimulus significantly increased CXCR4
gene expression compared with the no-stimulus and inflammatory stimulus groups (P<.01) (Figure 2A ). Although the difference between the hypoxia group and the dual-stimulus group was not statistically significant (P>.05), the combination of an inflammatory stimulus and hypoxic stimulus led to a more obvious increase in CXCR4 gene expression (Figure 2A) . No significant differences in CXCR4 gene expression were found between the no-stimulus, inflammation and hypoxia groups (P>.05). In the Western blot assay, cells from the dual-stimulus group displayed the highest CXCR4 protein expression level among the four groups ( Figure 2B,C Figure 2D ,E).
| The combination of inflammatory and hypoxic stimuli synergistically enhances BMMSC migration
In a tablet scratch experiment, the combination of inflammatory and hypoxic stimuli resulted in greater cell migration into the cell-free area than a single stimulus or no stimulus (P<.05 or P<.01) (Figure 3 ). 
F I G U R E 3
| Effects of different stimuli on cell proliferation and differentiation
When the effect of the inflammatory and/or hypoxic stimuli on BMMSC proliferation was evaluated via the MTT assay, both the inflammatory and hypoxic stimuli and the hypoxic stimulus alone exhibited a significant positive influence on cell proliferation compared with either no stimulus or the inflammatory stimulus (P<.05) ( Figure 5A ).
However, no synergistic effect was found in cells from the dualstimulus group compared with cells pretreated with hypoxia alone.
In addition, the inflammatory stimulus had no obvious effect on cell proliferation compared with the control (P>.05). Real-time PCR analysis revealed that the inflammatory stimulus and/or the hypoxia stimulus had no significant negative influence on the gene expression of
RUNX-2, ALP, OCN or PPAR-γ (P>.05) (
Figure 5B 
| Effects of different stimuli on cell immunomodulation
When the effect of the inflammatory and/or hypoxic stimuli on BMMSC immunomodulation was first evaluated via PBMNC proliferation assays, all of the evaluated cells exhibited significant immunosuppression of PBMNC proliferation compared with that of the positive control at all time points ( Figure 6A ). Statistical analysis showed that there was no significant difference in PBMNC proliferation between the four designated groups (P>.05). The percentages of PBMNC apoptosis were also detected following 72 hours of co-culture. All cell types appeared to promote PBMNC apoptosis compared with the control ( Figure 6B,C) ; similarly, no significant difference in PBMNC apoptosis was found between the four designated groups (P>.05).
| DISCUSSION
Compelling evidence suggests that impaired cell migration during the cell expansion process is associated with loss of the cell surface expression of C-X-C chemokine receptor type 4 (CXCR4). 16, 27 The interaction of CXCR4 with SDF-1α was found to mediate migration in ex vivo-expanded MSCs Taken together, the findings of this study demonstrate an effective cell pretreatment strategy that can be used to rescue the cell migration potential during in vitro expansion. However, understanding the in vitro control associated with both the dose and time of either the inflammatory or hypoxic stimulus will require further in-depth investigation.
| CONCLUSION
In this study, we report that the combination of a hypoxic stimulus and a low-dose inflammatory stimulus can be used to rescue BMMSC migration during ex vivo expansion. A low dose of inflammatory cytokines (ie, TNF-α at 1 ng/mL and IL-1β at 0.5 ng/mL) was not found to impair cell proliferation, differentiation or immunomodulation and functioned synergistically with a hypoxic stimulus to increase surface CXCR4 expression and in vitro migration in BMMSCs. These findings suggest that the combination of a hypoxic stimulus and a low-dose inflammatory stimulus may represent a reliable cell pretreatment system for future stem cell-based therapeutics.
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